Nasal insulin
Showing 1 - 25 of >10,000
Type 1 Diabetes, Diabetes, Type 1 Trial in Australia (Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®), Abatacept (CTLA4-Ig)
Recruiting
- Type 1 Diabetes
- Diabetes Mellitus, Type 1
- Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®)
- Abatacept (CTLA4-Ig) and nasal placebo (0.9% sodium chloride)
-
Westmead, New South Wales, Australia
- +5 more
Feb 15, 2023
Insulin Trial in Baton Rouge (Insulin, Regular, Human, Placebo)
Active, not recruiting
- Insulin
- Insulin, Regular, Human
- Placebo
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Aug 16, 2022
Central Insulin Resistance, Diabetes, Type 2, PreDiabetes Trial (Human nasal insulin, Placebo)
Not yet recruiting
- Central Insulin Resistance
- +2 more
- Human nasal insulin
- Placebo
- (no location specified)
May 12, 2023
Insulin Resistance Trial in Tübingen (nasal insulin, spray)
Recruiting
- Insulin Resistance
- nasal insulin
- placebo spray
-
Tübingen, GermanyUniversity of Tuebingen, Department of Internal Medicine IV
Mar 25, 2022
Mild Cognitive Impairment, Cognitive Impairment Trial in Winston-Salem (drug, other, device)
Active, not recruiting
- Mild Cognitive Impairment
- Cognitive Impairment
- Insulin
- +2 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jan 27, 2023
Mild Cognitive Impairment, Cognitive Impairment, Alzheimer, Early Onset Trial (Insulin (Humulin® R U-100), Placebo, Aptar Pharma
Not yet recruiting
- Mild Cognitive Impairment
- +2 more
- Insulin (Humulin® R U-100)
- +2 more
- (no location specified)
May 31, 2022
MDD Trial in Toronto (Humalog, Saline nasal spray)
Recruiting
- Major Depressive Disorder
- Humalog
- Saline nasal spray
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Oct 5, 2022
Mild Cognitive Impairment, Cognitive Impairment, Alzheimer Trial in Winston-Salem (Insulin (Humulin® R U-100), Empagliflozin 10
Recruiting
- Mild Cognitive Impairment
- +2 more
- Insulin (Humulin® R U-100)
- +4 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences / Wake Forest School of M
Nov 10, 2021
Alzheimer's Disease, Mild Cognitive Impairment Trial in Winston-Salem, Tacoma (Saline, Insulin detemir, Insulin)
Completed
- Alzheimer's Disease
- Mild Cognitive Impairment
- Saline
- +2 more
-
Winston-Salem, North Carolina
- +1 more
Nov 13, 2020
Ischemic Heart Disease, Aortic Aneurysm Trial in Montreal (Humulin R, Normal Saline)
Recruiting
- Ischemic Heart Disease
- Aortic Aneurysm
- Humulin R
- Normal Saline
-
Montreal, Quebec, CanadaRoyal Victoria Hospital McGill University Health Centre
Feb 23, 2021
Mild Cognitive Impairment, Cognitive Impairment Trial in Winston-Salem (20 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly &
Active, not recruiting
- Mild Cognitive Impairment
- Cognitive Impairment
- 20 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company)
- 40 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company)
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Nov 2, 2021
Insulin Resistance, Obesity Trial in Tübingen (Human nasal insulin, Placebo)
Completed
- Insulin Resistance
- Obesity
- Human nasal insulin
- Placebo
-
Tübingen, GermanyUniversity of Tuebingen, Department of Internal Medicine IV
Nov 4, 2020
Alzheimer's Disease, Mild Cognitive Impairment Trial in Winston-Salem (Insulin aspart, Placebo)
Completed
- Alzheimer's Disease
- Mild Cognitive Impairment
- Insulin aspart
- Placebo
-
Winston-Salem, North CarolinaWake Forest Baptist Hospital
May 8, 2020
Out-Of-Hospital Cardiac Arrest, Healthy Trial in Ann Arbor (Intranasal insulin)
Completed
- Out-Of-Hospital Cardiac Arrest
- Healthy
- Intranasal insulin
-
Ann Arbor, MichiganUniversity of Michigan
Oct 13, 2022
Healthy Trial in Ann Arbor (Intranasal insulin)
Recruiting
- Healthy
- Intranasal insulin
-
Ann Arbor, MichiganUniversity of Michigan
Nov 16, 2023
Amnestic Mild Cognitive Impairment, Alzheimer's Disease Trial in United States (Insulin (Humulin® R U-100), Placebo)
Completed
- Amnestic Mild Cognitive Impairment
- Alzheimer's Disease
- Insulin (Humulin® R U-100)
- Placebo
-
Phoenix, Arizona
- +24 more
May 14, 2020
Asthma, Obesity, Insulin Resistance Trial in Birmingham (Probiotic, Placebo)
Not yet recruiting
- Asthma
- +2 more
- Probiotic
- Placebo
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jul 7, 2023
Diabetes, Type 2 Trial in Tuebingen (intranasal insulin, Placebo)
Recruiting
- Diabetes Mellitus, Type 2
- intranasal insulin
- Placebo
-
Tuebingen, GermanyUniversity of Tuebingen, Department of Internal Medicine IV
Jun 24, 2021
Insulin Sensitivity Trial in Tuebingen (intranasal insulin, Placebo spray)
Completed
- Insulin Sensitivity
- intranasal insulin
- Placebo spray
-
Tuebingen, GermanyUniversity of Tuebingen, Department of Internal Medicine IV
Sep 2, 2021
Healthy, Vasodilation, Insulin Resistance Trial in Columbia (Carbon dioxide breathing, Neurovascular Coupling, Human insulin)
Recruiting
- Healthy
- +3 more
- Carbon dioxide breathing
- +2 more
-
Columbia, MissouriUniversity of Missouri
Feb 3, 2022
Postoperative Neurocognitive Disorders Trial in Xi'an (Intranasal insulin, Intranasal saline)
Recruiting
- Postoperative Neurocognitive Disorders
- Intranasal insulin
- Intranasal saline
-
Xi'an, Shannxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Nov 6, 2022
Type 2 Diabetic Patients: Real-life Study on Effectiveness and
Not yet recruiting
- Diabete Type 2
- (no location specified)
Nov 2, 2023
Insulin Resistance, Inflammatory Markers Trial in Cairo (low level laser in addition to diet recommendations, sham laser
Recruiting
- Insulin Resistance
- Inflammatory Markers
- low level laser in addition to diet recommendations
- sham laser application in addition to diet recommendations
-
Cairo, EgyptPhysical Therapy
Jun 17, 2022
Hypoglycemia Unawareness, Type 1 Diabetes Trial in Minneapolis (intra-nasal naloxone, Intra-nasal saline)
Terminated
- Hypoglycemia Unawareness
- Type 1 Diabetes
- intra-nasal naloxone
- Intra-nasal saline
-
Minneapolis, MinnesotaClinical and Translational Science Institute, University of Minn
Sep 26, 2022
Hypoglycemia Trial in Montreal (Nasal Glucagon 1 mg, Nasal Glucagon 2 mg, SC Glucagon)
Completed
- Hypoglycemia
- Nasal Glucagon 1 mg
- +3 more
-
Montreal, Quebec, CanadaAlgorithme Pharma
Sep 5, 2019